Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Streamlining Routine Chromatography Analyses using eWorkflows

12 Dec 2013 - 12 Dec 2013 - Webinar, 8:00am PST / 4:00pm GMT / 5:00pm CET / 11:00am EST



Bookmark and Share


Live Webcast:
Thursday, December 12, 2013
8:00am PST / 4:00pm GMT / 5:00pm CET / 11:00am EST

Event Overview 
When setting up a chromatography analysis it is often a requirement tofollow guidelines, like a standard operating procedure (SOP), for sequence creation, sample analysis and result calculation. But how do you ensure the rules of the SOPs are being routinely followed, especially during method transfer between laboratories? There are many areas where manual sequence creation can cause errors. 

This web seminar will showcase how the eWorkflows™ feature within the Thermo Scientific™ Dionex™ Chromeleon™ 7 Chromatography Data System (CDS) software provides a simple template for the fast creation of complete, correct sequences with pre-defined method and reportfiles and well-defined structures. We will demonstrate how eWorkflows have 
been applied in the Chromeleon Extension Pack to a routine application: USP 34 / EP 5.2 / BP2011 - Uniformity of Dosage Units. 

Learn how eWorkflows minimizes the amount of training required to run any analysis, safeguard method transfer, and take you from samples to reliable results in a minimum number of steps.

Key Learning Objectives 
• Chromeleon CDS is the most modern, gold standard CDS from Thermo Scientific with intelligent functionality, saving you time and money
• The Chromeleon Extension Pack provides eWorkflow templates for common routine analyses
• How eWorkflows can simplify reliable sequence creation and method transfer

Speaker
darrenbarrington-light.gif

Darren Barrington-Light, Product Specialist, Thermo Scientific




Moderator
: Ashley Board Ph. D., Managing Editor, Technology Networks



Further information
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!